BIODESIX INC·4

May 25, 6:21 PM ET

Kennedy Lawrence T. Jr 4

4 · BIODESIX INC · Filed May 25, 2023

Insider Transaction Report

Form 4
Period: 2023-05-23
Kennedy Lawrence T. Jr
Director10% Owner
Transactions
  • Award

    Restricted Stock Units

    2023-05-23+28,87328,873 total
    Common Stock (28,873 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.
  • [F3]Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer.
  • [F4]The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.

Documents

1 file
  • 4
    form4.xmlPrimary